---
document_datetime: 2023-09-21 20:29:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/copiktra-epar-all-authorised-presentations_en.pdf
document_name: copiktra-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6361868
conversion_datetime: 2025-12-23 06:36:43.177338
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number                    | (Invented) name   | Strength    | Pharmaceutical Form         | Route of Administration   | Immediate Packaging                                   | Pack size               |
|-----------------------------------|-------------------|-------------|-----------------------------|---------------------------|-------------------------------------------------------|-------------------------|
| EU/1/21/1542/001 EU/1/21/1542/002 | Copiktra Copiktra | 15 mg 25 mg | Capsule, hard Capsule, hard | Oral use Oral use         | blister (PVC/PE/PCTFE/alu) blister (PVC/PE/PCTFE/alu) | 56 capsules 56 capsules |